-
What value is the Artificial Tears Market expected to touch by 2033?
The Global Artificial Tears Market is expected to reach USD 780.03 million by 2033.
-
What CAGR is the Artificial Tears Market expected to exhibit by 2033?
The Artificial Tears Market is expected to exhibit a CAGR of 12.03% by 2033.
-
What are the driving factors of the Artificial Tears Market?
Increasing Prevalence of Dry Eye Syndrome and Growing Awareness of Eye Health to expand the market growth
-
What are the key Artificial Tears Market segments?
The key market segmentation, which includes, based on type, the Artificial Tears Market is Artificial Tear Liquid, Artificial Tear Ointment. Based on Downstream Industry, the Artificial Tears Market is classified as Dry Eyes Treatment, Contact Lenses Moisten, Others.
-
Who are some of the prominent players in the Artificial Tears industry?
Top players in the sector include Akorn Inc. (U.S), Johnson and Johnson Services, Inc. (U.S), Similasan Corporation (Switzerland), Aurolab (India), Alcon Inc. (Switzerland), Bayer AG (Germany), OASIS Medical (U.S), Bausch & Lomb (U.S), Santen Pharmaceutical Co., Ltd. (Japan), Ocusoft (U.S), AbbVie Inc. (U.S), Prestige Consumer Healthcare Inc. (U.S), Rohto (Japan), Ursapharm (Germany).
-
Which region is leading in the Artificial Tears Market?
North America is currently leading the Artificial Tears Market.